amyloid precursor protein C-terminal fragment-targeted monoclonal antibodies (Ecole Polytechnique Federale de Lausanne)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameamyloid precursor protein C-terminal fragment-targeted monoclonal antibodies (Ecole Polytechnique Federale de Lausanne)
Drug Alias Nameanti-APP-C99 mAbs (Ecole Polytechnique Federale de Lausanne)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEcole Polytechnique Federale De Lausanne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEcole Polytechnique Federale De Lausanne
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A